Distinguished in Metastatic Brain Tumor
Check Dr. Colette J. Shen's experience treating your condition:
About Dr. Colette J. Shen

Colette Shen is a Radiation Oncologist in Chapel Hill, North Carolina. Shen has been practicing medicine for over 11 years and is rated as a Distinguished expert by MediFind in the treatment of Metastatic Brain Tumor. She is also highly rated in 7 other conditions, according to our data. Her top areas of expertise are Metastatic Brain Tumor, Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Head and Neck Squamous Cell Carcinoma (HNSCC), and Gamma Knife Radiosurgery. She is licensed to treat patients in North Carolina. Shen is currently accepting new patients.

Her clinical research consists of co-authoring 51 peer reviewed articles and participating in 9 clinical trials in the past 15 years. In particular, she has co-authored 9 articles and participated in 1 clinical trial in the study of Metastatic Brain Tumor.


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Colette J. Shen it is best to call her office and ask if your insurance is accepted.

Accepts Medicare

Call to see if your plan is accepted.
101 Manning Dr, Chapel Hill, NC 27514
Background & Education
Graduate Institution
Perelman School Of Med At The University Of Pennsylvania, 2012
Radiation Oncology
Radiology in NC
Hospital Affiliations
UNC Medical Center
UNC Hospitals Hillsborough Campus
UNC Rockingham Health Care
Chatham Hospital
UNC Lenoir Health Care
Caldwell UNC Health Care
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

Phase II Randomized Trial of Neo-Adjuvant Chemotherapy Followed by Surgery and Post-Operative Radiation Versus Surgery and Post-Operative Radiation for Organ Preservation of T3 and T4a Nasal and Paranasal Sinus Squamous Cell Carcinoma (NPNSCC)
Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma
Phase I/II Study of Stereotactic Radiosurgery With Concurrent Administration of DNA Damage Response (DDR) Inhibitor (OLAparib) Followed by Adjuvant Combination of DuRvalumab (MEDI4736) and Physician's Choice Systemic Therapy in Subjects With BreAst Cancer Brain Metastases
Randomized Trial of Parotid Sparing Whole Brain Radiation
Functional Sparing of Salivary Glands Using MRI Sialography for Patients Undergoing Definitive Radiation Therapy for Head and Neck Cancers of the Oropharynx
AVATAR Anesthesia Alternative in Pediatric Radiotherapy: A Multi-Center Study
De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal Squamous Cell Carcinoma
View 6 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors